Log in

ASX:MYXMayne Pharma Group Stock Price, Forecast & News

Today's Range N/A
50-Day Range
MA: A$0.43
52-Week Range N/A
Volume5.47 million shs
Average Volume6.32 million shs
Market Capitalization$713.61 million
P/E RatioN/A
Dividend YieldN/A
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products worldwide. It operates through four segments: Generic Products, Specialty Brands, Metrics Contract Services, and Mayne Pharma International. The company also offers oral drug delivery systems; and contract development and manufacturing services to third-party customers. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited is based in Salisbury South, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.54 out of 5 stars

Industry, Sector and Symbol

Industry Drug Manufacturers - Major



Sales & Book Value

Annual Sales$477.99 million
Book ValueA$0.65 per share



Outstanding Shares1,679,069,952
Market Cap$713.61 million
Next Earnings Date8/21/2020 (Estimated)
OptionableNot Optionable

Receive MYX News and Ratings via Email

Sign-up to receive the latest news and ratings for MYX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Mayne Pharma Group (ASX:MYX) Frequently Asked Questions

When is Mayne Pharma Group's next earnings date?

Mayne Pharma Group is scheduled to release its next quarterly earnings announcement on Friday, August 21st 2020.
View our earnings forecast for Mayne Pharma Group

How were Mayne Pharma Group's earnings last quarter?

Mayne Pharma Group Ltd (ASX:MYX) posted its quarterly earnings results on Friday, February, 22nd. The company reported $0.02 earnings per share (EPS) for the quarter.
View Mayne Pharma Group's earnings history

Has Mayne Pharma Group been receiving favorable news coverage?

Headlines about MYX stock have been trending somewhat negative this week, InfoTrie reports. The research group identifies negative and positive press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Mayne Pharma Group earned a news sentiment score of -1.9 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near future.
View the latest news about Mayne Pharma Group

Who are some of Mayne Pharma Group's key competitors?

What other stocks do shareholders of Mayne Pharma Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Mayne Pharma Group investors own include SUNDANCE ENERGY/S (SNDE), Aurora Cannabis (ACB), Turquoise Hill Resources (TRQ), Telstra (TLS), Green Organic Dutchman (TGODF), Perseus Mining (PRU), OrganiGram (OGI), Karoon Energy (KAR), Crown Resorts (CWN) and Cronos Group (CRON).

Who are Mayne Pharma Group's key executives?

Mayne Pharma Group's management team includes the following people:
  • Mr. Scott Anthony Richards, MD, CEO & Exec. Director (Age 55)
  • Mr. Nick Freeman BCom, CA, Group CFO & Company Sec.
  • Mr. Stefan J. Cross, Pres of International Operations (Age 46)
  • Dr. Ilana Stancovski, Chief Scientific Officer & Head of European Market Devel.
  • Ms. Lisa Pendlebury, VP of Investor Relations & Communications

What is Mayne Pharma Group's stock symbol?

Mayne Pharma Group trades on the ASX under the ticker symbol "MYX."

How big of a company is Mayne Pharma Group?

Mayne Pharma Group has a market capitalization of $0.00 and generates $477.99 million in revenue each year. Mayne Pharma Group employs 780 workers across the globe.

What is Mayne Pharma Group's official website?

The official website for Mayne Pharma Group is www.maynepharma.com.

How can I contact Mayne Pharma Group?

Mayne Pharma Group's mailing address is 1538 Main North Rd, ADELAIDE, SA 5106, Australia. The company can be reached via phone at +61-8-82092666.

This page was last updated on 8/11/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.